Informacje dodatkowe
| Active substance | FTTP |
|---|---|
| Formula | C111H204N36O28S2 |
| Side effects | Potential renal toxicity, dehydration, alterations in blood pressure |
| Effects | Promotes weight loss by targeting and killing vascular cells in adipose tissue |
| Dosage (sports) | Not applicable, as it is not typically used for athletic enhancement |
| Dosage (medical) | Generally, initial doses used in studies were around 0.43 mg/kg/day |
| Half-life | Approximately 30 hours |
| Main action | Induces apoptosis in blood vessels supplying adipose tissue |
| Substance class | Peptide |
| Chemical name | CKGGRAKDC-GG- D(KLAKLAK)2 |
| Storage conditions | Store in a cool, dry place, away from light, typically at 2-8В°C |
| Trade name | Not commercially available under any trade name as of last reports |
| Blood pressure | Can cause alterations in blood pressure, monitoring advised |
| WAREHOUSE | International Warehouse 3 |
| Also known as | FTPP (Fat Targeted Proapoptotic Peptide) |
| Lab Test | Specific tests for adipotide are not commonly available in standard medical settings |
| Hepatotoxicity | No significant hepatotoxicity reported in studies |
| Water Retention | No significant water retention reported |
| Use in sports | Not commonly used in sports due to its specific mechanism targeting fat loss and potential health risks |
| Manufacturer | Ultima Peptides |
|
Opinie
Na razie nie ma opinii o produkcie.